Literature DB >> 8698064

Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures.

A Schomburg1, H Bender, C Reichel, T Sommer, J Ruhlmann, B Kozak, H J Biersack.   

Abstract

While the evident advantages of absolute metabolic rate determinations cannot be equalled by static image analysis of fluorine-18 fluorodeoxyglucose positron emission tomographic (FDG PET) studies, various algorithms for the normalization of static FDG uptake values have been proposed. This study was performed to compare different normalization procedures in terms of dependency on individual patient characteristics. Standardized FDG uptake values (SUVs) were calculated for liver and lung tissue in 126 patients studied with whole-body FDG PET. Uptake values were normalized for total body weight, lean body mass and body surface area. Ranges, means, medians, standard deviations and variation coefficients of these SUV parameters were calculated and their interdependency with total body weight, lean body mass, body surface area, patient height and blood sugar levels was calculated by means of regression analysis. Standardized FDG uptake values normalized for body surface area were clearly superior to SUV parameters normalized for total body weight or lean body mass. Variation and correlation coefficients of body surface area-normalized uptake values were minimal when compared with SUV parameters derived from the other normalization procedures. Normalization for total body weight resulted in uptake values still dependent on body weight and blood sugar levels, while normalization for lean body mass did not eliminate the positive correlation with lean body mass and patient height. It is concluded that normalization of FDG uptake values for body surface area is less dependent on the individual patient characteristics than are FDG uptake values normalized for other parameters, and therefore appears to be preferable for FDG PET studies in oncology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698064     DOI: 10.1007/bf00833394

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  Whole-body positron emission tomography: Part I. Methods and performance characteristics.

Authors:  M Dahlbom; E J Hoffman; C K Hoh; C Schiepers; G Rosenqvist; R A Hawkins; M E Phelps
Journal:  J Nucl Med       Date:  1992-06       Impact factor: 10.057

2.  PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose.

Authors:  L K Griffeth; F Dehdashti; A H McGuire; D J McGuire; D J Perry; S M Moerlein; B A Siegel
Journal:  Radiology       Date:  1992-01       Impact factor: 11.105

3.  PET quantitation: blessing and curse.

Authors:  G Di Chiro; R A Brooks
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

4.  Standardized uptake values of FDG.

Authors:  S Leskinen-Kallio; H Minn; K R Zasadny
Journal:  J Nucl Med       Date:  1994-09       Impact factor: 10.057

Review 5.  The applications of PET in clinical oncology.

Authors:  L G Strauss; P S Conti
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

6.  Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction.

Authors:  C K Kim; N C Gupta
Journal:  Nucl Med Commun       Date:  1996-10       Impact factor: 1.690

7.  Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.

Authors:  C K Kim; N C Gupta; B Chandramouli; A Alavi
Journal:  J Nucl Med       Date:  1994-01       Impact factor: 10.057

8.  Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.

Authors:  K R Zasadny; R L Wahl
Journal:  Radiology       Date:  1993-12       Impact factor: 11.105

9.  Characterization of chest masses by FDG positron emission tomography.

Authors:  K F Hübner; E Buonocore; S K Singh; H R Gould; D W Cotten
Journal:  Clin Nucl Med       Date:  1995-04       Impact factor: 7.794

  9 in total
  13 in total

1.  Is quantitation necessary for oncological PET studies? Against.

Authors:  Michael M Graham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-01       Impact factor: 9.236

Review 2.  Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.

Authors:  Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-22       Impact factor: 9.236

3.  Standardized uptake value atlas: characterization of physiological 2-deoxy-2-[18F]fluoro-D-glucose uptake in normal tissues.

Authors:  Yingbing Wang; Edison Chiu; Jarrett Rosenberg; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2007 Mar-Apr       Impact factor: 3.488

4.  A weight index for the standardized uptake value in 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography.

Authors:  Joseph A Thie; Karl F Hubner; Francis P Isidoro; Gary T Smith
Journal:  Mol Imaging Biol       Date:  2007 Mar-Apr       Impact factor: 3.488

5.  The clinical consequences of functional adrenal uptake in the absence of cross-sectional mass on FDG-PET/CT in oncology patients.

Authors:  Ralph Hsiao; Alicia Chow; Wouter P Kluijfhout; Pim J Bongers; Raoul Verzijl; Ur Metser; Patrick Veit-Haibach; Jesse D Pasternak
Journal:  Langenbecks Arch Surg       Date:  2022-01-07       Impact factor: 2.895

6.  Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.

Authors:  Nanda C Krak; Jacobus J M van der Hoeven; Otto S Hoekstra; Jos W R Twisk; Elsken van der Wall; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-15       Impact factor: 9.236

Review 7.  Methodological considerations in quantification of oncological FDG PET studies.

Authors:  Dennis Vriens; Eric P Visser; Lioe-Fee de Geus-Oei; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-20       Impact factor: 9.236

8.  In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia.

Authors:  Craig K Abbey; Alexander D Borowsky; Erik T McGoldrick; Jeffrey P Gregg; Jeannie E Maglione; Robert D Cardiff; Simon R Cherry
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

9.  Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience.

Authors:  Joshua S Scheuermann; Janet R Saffer; Joel S Karp; Anthony M Levering; Barry A Siegel
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

10.  A dedicated paediatric [18F]FDG PET/CT dosage regimen.

Authors:  Christina P W Cox; Daniëlle M E van Assema; Frederik A Verburg; Tessa Brabander; Mark Konijnenberg; Marcel Segbers
Journal:  EJNMMI Res       Date:  2021-07-19       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.